Inogen Inc
$ 6.49
-1.07%
06 Aug - close price
- Market Cap 177,609,000 USD
- Current Price $ 6.49
- High / Low $ 6.71 / 6.45
- Stock P/E N/A
- Book Value 6.68
- EPS -0.86
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.06 %
- ROE -0.13 %
- 52 Week High 9.13
- 52 Week Low 5.34
About
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
Analyst Target Price
$12.67
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-07 | 2026-02-24 | 2025-11-05 | 2025-08-07 | 2025-05-07 | 2025-02-25 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-02-27 | 2023-11-07 |
| Reported EPS | -0.15 | -0.14 | -0.15 | -0.2 | -0.15 | -0.11 | -0.24 | -0.11 | -0.07 | -0.45 | -1.14 | -0.36 |
| Estimated EPS | -0.17 | -0.21 | -0.3424 | -0.22 | -0.22 | -0.25 | -0.49 | -0.27 | -0.39 | -0.58 | -0.62 | -0.23 |
| Surprise | 0.02 | 0.07 | 0.1924 | 0.02 | 0.07 | 0.14 | 0.25 | 0.16 | 0.32 | 0.13 | -0.52 | -0.13 |
| Surprise Percentage | 11.7647% | 33.3333% | 56.1916% | 9.0909% | 31.8182% | 56% | 51.0204% | 59.2593% | 82.0513% | 22.4138% | -83.871% | -56.5217% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: INGN
2026-08-07 05:04:08
Inogen Inc. (INGN) reported strong international revenue growth of 15% year-over-year and core POC unit volume growth of over 12% in Q2 2026, with new products Voxy and Aurora gaining traction. Despite these positive indicators and an expanded gross margin, the company lowered its full-year 2026 revenue guidance due to declining U.S. sales and rental revenue, reflecting channel mix challenges and a structural market shift. Inogen maintains a strong balance sheet and increased its adjusted EBITDA guidance, while actively addressing the U.S. market headwinds and exploring new product opportunities.
2026-08-06 23:10:09
Inogen (INGN) reported a Q2 loss of $0.14 per share, which was better than the Zacks Consensus Estimate of a $0.17 loss, and also surpassed revenue estimates with $95.08 million. Despite underperforming the S&P 500 year-to-date, the company's stock currently holds a Zacks Rank #3 (Hold), indicating an expected performance in line with the market. Investors are advised to monitor management's commentary and future estimate revisions.
2026-08-06 22:10:09
Inogen Inc (NASDAQ: INGN) reported its second-quarter earnings, beating analyst EPS estimates by $0.03 with an EPS of $-0.14. The company also surpassed revenue expectations, bringing in $95.1M against a consensus estimate of $95.05M. Despite the beat, the stock has seen a -7.83% decline in the last three months, though it is up 10.22% over the last year, with its financial health rated as "good performance" by InvestingPro.
2026-07-28 12:10:27
Inogen, Inc. (NASDAQ: INGN) generated $348.67 million USD in revenue last year. The primary driver of this revenue was the Oxygen Concentrators and Related Accessories segment, contributing $295.30 million USD. Geographically, the United States was the largest contributor to the company's revenue, accounting for $209.84 million USD.
2026-07-26 23:41:13
This article provides a detailed cash flow statement for Inogen Inc (INGN), outlining quarterly and annual data for operating, investing, and financing activities. It includes key financial metrics such as net income, capital expenditures, and free cash flow, along with year-over-year percentage changes. The article also features an FAQ section explaining various cash flow components and their significance for investors.
2026-07-26 12:10:27
This article provides a detailed company profile for Inogen Inc (INGN), a medical technology company specializing in respiratory products like portable oxygen concentrators. It covers the company's background, business scope, key products such as the Inogen One and Inogen Rove systems, and executive information. The article also touches on market performance, shareholder details, and institutional holdings.
